Mian Zu

Mian Zu

Auto-generated profile, based on publicly available information

Mian Zu

Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2015 in Molecules
Verified
Journal Article
Open access
PDF file
MZMian Zu
Mian Zu
CLChao Li
Chao Li
JFJian-Song Fang
Jian-Song Fang
WLWen-Wen Lian
Wen-Wen Lian
LALiu Ailin
Liu Ailin
GDGuanhua Du
Guanhua Du
The rapid evolution of influenza virus makes antiviral drugs less effective, which is considered to be a major bottleneck in antiviral therapy. The key proteins in the host cells, which are related with the replication cycle of influenza virus, are regarded as potential drug targets due to their distinct advantage of lack of evolution and drug resistance. Cdc2-like kinase 1 (CLK1) in the host cells is responsible for alternative splicing of the M2 gene of influenza virus during influenza infection and replication. In this study, we carried out baculovirus-mediated expression and purification of CLK1 and established a reliable screening assay for CLK1 inhibitors. After a virtual screening of CLK1 inhibitors was performed, the activities of the selected compounds were evaluated. Finally, several compounds with strong inhibitory activity against CLK1 were discovered and their in vitro anti-influenza virus activities were validated using a cytopathic effect (CPE) reduction assay. The assay results showed that clypearin, corilagin, and pinosylvine were the most potential anti-influenza virus compounds as CLK1 inhibitors among the compounds tested. These findings will provide important information for new drug design and development in influenza treatment, and CLK1 may be a potent drug target for anti-influenza drug screening and discovery.

1 October 2012
Verified
Journal Article
Closed access
KCKao-Tan Chen
Kao-Tan Chen
WZWei-Ling Zhou
Wei-Ling Zhou
JLJiawei Liu
Jiawei Liu
MZMian Zu
Mian Zu
ZHZi-Ning He
Zi-Ning He
LALiu Ailin
Liu Ailin

1 March 2010
Verified
Journal Article
Closed access
MZMian Zu
Mian Zu
DZDan Zhou
Dan Zhou
LGLi Gao
Li Gao
LALiu Ailin
Liu Ailin
GDGuanhua Du
Guanhua Du